The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)
Open accessAbstract
The 9- t -butylglycylamido derivative of minocycline (TBG-MINO) is a recently synthesized member of a novel group of antibiotics, the glycylcyclines. This new derivative, like the first glycylcyclines, the N , N -dimethylglycylamido derivative of minocycline and 6-demethyl-6-deoxytetracycline, possesses activity against bacterial isolates containing the two major determinants responsible for tetracycline resistance: ribosomal protection and active efflux. The in vitro activities of TBG-MINO and the comparative agents were evaluated against strains with characterized tetracycline resistance as well as a spectrum of recent clinical aerobic and anaerobic gram-positive and gram-negative bacteria. TBG-MINO, with an MIC range of 0.25 to 0.5 μg/ml, showed good activity against strains expressing tet (M) (ribosomal protection), tet (A), tet (B), tet (C), tet (D), and tet (K) (efflux resistance determinants). TBG-MINO exhibited similar activity against methicillin-resistant Staphylococcus aureus (MRSA), penicillin-resistant streptococci, and vancomycin-resistant enterococci (MICs at which 90% of strains are inhibited, ≤0.5 μg/ml). TBG-MINO exhibited activity against a wide diversity of gram-negative aerobic and anaerobic bacteria, most of which were less susceptible to tetracycline and minocycline. The in vivo protective effects of TBG-MINO were examined against acute lethal infections in mice caused by Escherichia coli , S. aureus , and Streptococcus pneumoniae isolates. TBG-MINO, administered intravenously, demonstrated efficacy against infections caused by S. aureus including MRSA strains and strains containing tet (K) or tet (M) resistance determinants (median effective doses [ED 50 s], 0.79 to 2.3 mg/kg of body weight). TBG-MINO demonstrated efficacy against infections caused by tetracycline-sensitive E. coli strains as well as E. coli strains containing either tet (M) or the efflux determinant tet (A), tet (B), or tet (C) (ED 50 s, 1.5 to 3.5 mg/kg). Overall, TBG-MINO shows antibacterial activity against a wide spectrum of gram-positive and gram-negative aerobic and anaerobic bacteria including strains resistant to other chemotherapeutic agents. The in vivo protective effects, especially against infections caused by resistant bacteria, corresponded with the in vitro activity of TBG-MINO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Lewis, J. A., & Finney, D. (1972) · Applied Statistics · doi:10.2307/2346498 · Cited by 2,665
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Wadsworth anaerobic bacteriology manual
Sutter, V. L., Citron, D. M., & Finegold, S. M. (1980) · Medical Entomology and Zoology · Cited by 1,388
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Identification of Enterococcus species isolated from human infections by a conventional test scheme
Facklam, R. R., & Collins, M. D. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.4.731-734.1989 · Cited by 791
Mulligan, M. E., Murray-Leisure, K. A., Ribner, B. S., Standiford, H. C., John, J. F., Korvick, J. A., Kauffman, C. A., & Yu, V. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90063-u · Cited by 641
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance
Speer, B. S., Shoemaker, N. B., & Salyers, A. A. (1992) · Clinical Microbiology Reviews · doi:10.1128/cmr.5.4.387 · Cited by 517
AUREOMYCIN: A PRODUCT OF THE CONTINUING SEARCH FOR NEW ANTIBIOTICS
Duggar, B. M. (1948) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1948.tb27262.x · Cited by 512
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
Sahm, D. F., Kissinger, J., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1588 · Cited by 497
Tetracyclines, molecular and clinical aspects
Chopra, I., Hawkey, P. M., & Hinton, M. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/29.3.245 · Cited by 421
Handwerger, S., Raucher, B., Altarac, D., Monka, J., Marchione, S., Singh, K. V., Murray, B. E., Wolff, J., & Walters, B. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.6.750 · Cited by 421
Grayson, M. L., Eliopoulos, G. M., Wennersten, C. B., Ruoff, K. L., De Girolami, P. C., Ferraro, M. J., & Moellering, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2180 · Cited by 195
TESTA, R. T., Petersen, P. J., Jacobus, N. V., Sum, P., LEE, V. J., & Tally, F. P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2270 · Cited by 121
Self-citationResistance to the Tetracyclines
Levy, S. B. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-138120-2.50012-5 · Cited by 121
Sum, P., LEE, V. J., TESTA, R. T., Hlavka, J. J., Ellestad, G. A., Bloom, J. D., Gluzman, Y., & Tally, F. P. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00027a023 · Cited by 118
Self-citationMason, E. O., Kaplan, S. L., Lamberth, L. B., & Tillman, J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.8.1703 · Cited by 109
Evolution and spread of tetracycline resistance determinants
Levy, S. B. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.1.1 · Cited by 106
Nomenclature for tetracycline resistance determinants
Levy, S. B., McMurry, L. M., Burdett, V., Courvalin, P. M., Hillen, W., Roberts, M. C., & Taylor, D. E. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1373 · Cited by 100
New perspectives in tetracycline resistance
Salyers, A. A., Speer, B. S., & Shoemaker, N. B. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02025.x · Cited by 95
In vitro activities of two glycylcyclines against gram-positive bacteria
Eliopoulos, G. M., Wennersten, C. B., Cole, G., & Moellering, R. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.534 · Cited by 48
Shales, S. W., Chopra, I., & Ball, P. R. (1980) · Microbiology · doi:10.1099/00221287-121-1-221 · Cited by 35
In vitro activities of two glycylcyclines
Wise, R. A., & Andrews, J. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1096 · Cited by 30
Goldstein, F. W., Kitzis, M.-D., & Acar, J. F. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2218 · Cited by 30
Kenny, G. E., & Cartwright, F. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.11.2628 · Cited by 23
Chopra, I., Shales, S. W., & Ball, P. (1982) · Microbiology · doi:10.1099/00221287-128-4-689 · Cited by 16
In vitro activity of DMG-mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria
Nord, C. E., Lindmark, A., & Persson, I. (1993) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02098471 · Cited by 13
Wexler, H. M., Molitoris, E., & Finegold, S. M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2513 · Cited by 13
Cited by
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 1,955
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Metadata
- Authors
- Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., & Testa, R. T.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-04
- Volume
- 43
- Issue
- 4
- Pages
- 738-744
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2156737450
- Cited by
- 415
- References
- 30
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.